| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration | 1.10e-05 | 2 | 69 | 2 | GO:0021816 | |
| GeneOntologyBiologicalProcess | pseudopodium assembly | 2.36e-05 | 17 | 69 | 3 | GO:0031269 | |
| GeneOntologyBiologicalProcess | pseudopodium organization | 3.34e-05 | 19 | 69 | 3 | GO:0031268 | |
| GeneOntologyCellularComponent | INO80-type complex | 1.11e-04 | 28 | 70 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | nuclear chromosome | 2.08e-04 | 254 | 70 | 6 | GO:0000228 | |
| GeneOntologyCellularComponent | synaptonemal complex | 4.92e-04 | 46 | 70 | 3 | GO:0000795 | |
| GeneOntologyCellularComponent | synaptonemal structure | 4.92e-04 | 46 | 70 | 3 | GO:0099086 | |
| GeneOntologyCellularComponent | condensed chromosome | 5.69e-04 | 307 | 70 | 6 | GO:0000793 | |
| GeneOntologyCellularComponent | cell body fiber | 5.96e-04 | 11 | 70 | 2 | GO:0070852 | |
| GeneOntologyCellularComponent | Swr1 complex | 8.42e-04 | 13 | 70 | 2 | GO:0000812 | |
| GeneOntologyCellularComponent | dendritic spine head | 1.29e-03 | 16 | 70 | 2 | GO:0044327 | |
| Domain | srGAP2 | 4.62e-08 | 3 | 68 | 3 | IPR030252 | |
| Domain | FCH | 6.76e-05 | 22 | 68 | 3 | PF00611 | |
| Domain | FCH | 6.76e-05 | 22 | 68 | 3 | SM00055 | |
| Domain | FCH_dom | 7.76e-05 | 23 | 68 | 3 | IPR001060 | |
| Domain | F_BAR | 1.00e-04 | 25 | 68 | 3 | IPR031160 | |
| Domain | F_BAR | 1.00e-04 | 25 | 68 | 3 | PS51741 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.78e-04 | 35 | 68 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 3.55e-04 | 38 | 68 | 3 | PS00690 | |
| Domain | - | 5.77e-04 | 10 | 68 | 2 | 4.10.1060.10 | |
| Domain | RRM_1 | 9.63e-04 | 208 | 68 | 5 | PF00076 | |
| Domain | RRM | 1.16e-03 | 217 | 68 | 5 | SM00360 | |
| Domain | RRM_dom | 1.42e-03 | 227 | 68 | 5 | IPR000504 | |
| Domain | RRM | 1.50e-03 | 230 | 68 | 5 | PS50102 | |
| Domain | CH | 1.72e-03 | 65 | 68 | 3 | SM00033 | |
| Domain | - | 1.95e-03 | 244 | 68 | 5 | 3.30.70.330 | |
| Domain | CH | 2.12e-03 | 70 | 68 | 3 | PF00307 | |
| Domain | - | 2.21e-03 | 71 | 68 | 3 | 1.10.418.10 | |
| Domain | CH | 2.39e-03 | 73 | 68 | 3 | PS50021 | |
| Domain | Nucleotide-bd_a/b_plait | 2.48e-03 | 258 | 68 | 5 | IPR012677 | |
| Domain | CH-domain | 2.58e-03 | 75 | 68 | 3 | IPR001715 | |
| Domain | zf-RanBP | 2.88e-03 | 22 | 68 | 2 | PF00641 | |
| Domain | G_patch | 3.15e-03 | 23 | 68 | 2 | SM00443 | |
| Domain | G_patch_dom | 3.15e-03 | 23 | 68 | 2 | IPR000467 | |
| Domain | ZnF_RBZ | 3.15e-03 | 23 | 68 | 2 | SM00547 | |
| Domain | G_PATCH | 3.15e-03 | 23 | 68 | 2 | PS50174 | |
| Domain | ZF_RANBP2_2 | 3.15e-03 | 23 | 68 | 2 | PS50199 | |
| Domain | G-patch | 3.15e-03 | 23 | 68 | 2 | PF01585 | |
| Domain | ZF_RANBP2_1 | 3.42e-03 | 24 | 68 | 2 | PS01358 | |
| Domain | P-loop_NTPase | 3.50e-03 | 848 | 68 | 9 | IPR027417 | |
| Pubmed | ERICH1 TUT4 EP400 N4BP2 RBM26 XRN1 APC RBM5 SRGAP2 DNAJA1 JMJD1C GOLGA4 TFRC | 3.30e-09 | 733 | 72 | 13 | 34672954 | |
| Pubmed | BLM SETD1A RIF1 TAF3 NOP14 EP400 ADRM1 TNPO2 RBM10 CFDP1 XRN1 MRPS11 YY1AP1 DNAJA1 JMJD1C RBM34 TFRC | 3.93e-09 | 1429 | 72 | 17 | 35140242 | |
| Pubmed | 8.51e-09 | 3 | 72 | 3 | 22559944 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.53e-08 | 440 | 72 | 10 | 34244565 | |
| Pubmed | Evolution of human-specific neural SRGAP2 genes by incomplete segmental duplication. | 3.40e-08 | 4 | 72 | 3 | 22559943 | |
| Pubmed | BLM ABCF1 NOP14 SND1 SACS N4BP2 SYNE1 NECTIN2 MRPS11 EMC10 DNA2 DNAJA1 DHX29 GOLGA4 RBM34 TFRC | 4.92e-08 | 1487 | 72 | 16 | 33957083 | |
| Pubmed | BLM POLR1F RIF1 ABCF1 NOP14 EP400 COPZ1 SND1 SYNE1 RBM26 XRN1 APC RBM5 SRGAP2 DHX29 LRCH3 | 5.39e-08 | 1497 | 72 | 16 | 31527615 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 6.16e-08 | 256 | 72 | 8 | 33397691 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | BLM TAF3 ABCF1 NOP14 EP400 SACS SYNE1 RBM10 MRPS11 APC RBM5 EDIL3 DNAJA1 | 3.08e-07 | 1082 | 72 | 13 | 38697112 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 RIF1 ABCF1 EP400 SND1 RBM10 CFDP1 RBM26 XRN1 SRGAP2 DHX29 UBFD1 | 4.59e-07 | 934 | 72 | 12 | 33916271 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 5.46e-07 | 341 | 72 | 8 | 32971831 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | BLM POLR1F SETD1A RIF1 ABCF1 NOP14 EP400 SND1 XRN1 DNAJA1 DHX29 GOLGA4 RBM34 TFRC | 6.15e-07 | 1353 | 72 | 14 | 29467282 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | TUT4 ABCF1 NOP14 SND1 SYNE1 RBM26 XRN1 MRPS11 RBM5 DHX29 RBM34 | 8.18e-07 | 807 | 72 | 11 | 22681889 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | BLM POLR1F RIF1 NOP14 SND1 RBM10 RBM26 MRPS11 RBM5 DNAJA1 JMJD1C TFRC | 8.37e-07 | 989 | 72 | 12 | 36424410 |
| Pubmed | BLM POLR1F RIF1 TAF3 EP400 SND1 ADRM1 CFDP1 RBM26 DNAJA1 UBFD1 TFRC | 1.09e-06 | 1014 | 72 | 12 | 32416067 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 1.61e-06 | 394 | 72 | 8 | 27248496 | |
| Pubmed | 1.97e-06 | 708 | 72 | 10 | 39231216 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.06e-06 | 283 | 72 | 7 | 30585729 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 3.66e-06 | 759 | 72 | 10 | 35915203 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28662214 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 31822692 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 27373832 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 28586478 | ||
| Pubmed | Cancer predisposition caused by elevated mitotic recombination in Bloom mice. | 4.23e-06 | 2 | 72 | 2 | 11101838 | |
| Pubmed | Enhanced tumor formation in mice heterozygous for Blm mutation. | 4.23e-06 | 2 | 72 | 2 | 12242442 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.35e-06 | 774 | 72 | 10 | 15302935 | |
| Pubmed | 4.50e-06 | 777 | 72 | 10 | 35844135 | ||
| Pubmed | 4.50e-06 | 453 | 72 | 8 | 29656893 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RIF1 ABCF1 SND1 SYNE1 RBM26 RBM5 MYO18B DNAJA1 DNAH5 DHX29 GOLGA4 RBM34 TFRC | 6.47e-06 | 1425 | 72 | 13 | 30948266 |
| Pubmed | 7.51e-06 | 486 | 72 | 8 | 20936779 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 8.96e-06 | 134 | 72 | 5 | 25452129 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | POLR1F EHBP1 EXPH5 N4BP2 NECTIN2 XRN1 APC LMTK2 SRGAP2 GOLGA4 | 1.10e-05 | 861 | 72 | 10 | 36931259 |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 27612385 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 26784654 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 25122754 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 19690388 | ||
| Pubmed | Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. | 1.27e-05 | 3 | 72 | 2 | 15959913 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 28862703 | ||
| Pubmed | 1.37e-05 | 250 | 72 | 6 | 33536335 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | BLM EHBP1 RIF1 TLK1 ABCF1 COPZ1 SND1 ADRM1 NECTIN2 SRGAP2 RSPH10B LRCH3 | 1.60e-05 | 1321 | 72 | 12 | 27173435 |
| Pubmed | 1.64e-05 | 713 | 72 | 9 | 29802200 | ||
| Pubmed | 1.76e-05 | 547 | 72 | 8 | 37267103 | ||
| Pubmed | 1.81e-05 | 549 | 72 | 8 | 38280479 | ||
| Pubmed | 1.82e-05 | 263 | 72 | 6 | 34702444 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 2.22e-05 | 565 | 72 | 8 | 25468996 | |
| Pubmed | Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1. | 2.53e-05 | 4 | 72 | 2 | 33972400 | |
| Pubmed | A type I DnaJ homolog, DjA1, regulates androgen receptor signaling and spermatogenesis. | 2.53e-05 | 4 | 72 | 2 | 15660130 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 24332178 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 31153714 | ||
| Pubmed | 3.08e-05 | 971 | 72 | 10 | 33306668 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.73e-05 | 608 | 72 | 8 | 36089195 | |
| Pubmed | TLK1 NOP14 SND1 SACS PCDHGA10 N4BP2 SYNE1 XRN1 RBM5 OTUD3 DNAJA1 TFRC | 3.78e-05 | 1442 | 72 | 12 | 35575683 | |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 3.94e-05 | 91 | 72 | 4 | 34780483 | |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 20711169 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 25712475 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 22025255 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 4.81e-05 | 1024 | 72 | 10 | 24711643 | |
| Pubmed | 5.59e-05 | 472 | 72 | 7 | 38943005 | ||
| Pubmed | 6.16e-05 | 653 | 72 | 8 | 22586326 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 21325134 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.57e-05 | 203 | 72 | 5 | 22083510 | |
| Pubmed | 7.33e-05 | 493 | 72 | 7 | 15368895 | ||
| Pubmed | 7.43e-05 | 494 | 72 | 7 | 26831064 | ||
| Pubmed | 7.46e-05 | 339 | 72 | 6 | 37232246 | ||
| Pubmed | 7.58e-05 | 340 | 72 | 6 | 24332808 | ||
| Pubmed | 7.62e-05 | 496 | 72 | 7 | 31343991 | ||
| Pubmed | Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men. | 8.82e-05 | 7 | 72 | 2 | 19866473 | |
| Pubmed | 8.91e-05 | 1103 | 72 | 10 | 34189442 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.16e-04 | 120 | 72 | 4 | 31413325 | |
| Pubmed | 1.16e-04 | 1139 | 72 | 10 | 36417873 | ||
| Pubmed | 1.17e-04 | 8 | 72 | 2 | 20450899 | ||
| Pubmed | DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells. | 1.17e-04 | 8 | 72 | 2 | 30464262 | |
| Pubmed | Established prostate cancer susceptibility variants are not associated with disease outcome. | 1.17e-04 | 8 | 72 | 2 | 19423541 | |
| Pubmed | 1.17e-04 | 8 | 72 | 2 | 19900942 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 1.20e-04 | 719 | 72 | 8 | 35337019 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 1.25e-04 | 1149 | 72 | 10 | 35446349 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.26e-04 | 724 | 72 | 8 | 36232890 | |
| Pubmed | 1.46e-04 | 551 | 72 | 7 | 34728620 | ||
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 19318432 | ||
| Pubmed | A dicer-independent miRNA biogenesis pathway that requires Ago catalysis. | 1.51e-04 | 9 | 72 | 2 | 20424607 | |
| Pubmed | A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis. | 1.51e-04 | 9 | 72 | 2 | 25362351 | |
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 34489457 | ||
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 39128004 | ||
| Pubmed | 1.55e-04 | 50 | 72 | 3 | 37974198 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.79e-04 | 398 | 72 | 6 | 35016035 | |
| Pubmed | A balance between elongation and trimming regulates telomere stability in stem cells. | 1.88e-04 | 10 | 72 | 2 | 27918544 | |
| Pubmed | 1.88e-04 | 10 | 72 | 2 | 23509288 | ||
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 2.07e-04 | 55 | 72 | 3 | 38945485 | |
| Pubmed | 2.21e-04 | 142 | 72 | 4 | 30217970 | ||
| Pubmed | 2.30e-04 | 11 | 72 | 2 | 19549807 | ||
| Pubmed | The Ets2 Repressor Factor (Erf) Is Required for Effective Primitive and Definitive Hematopoiesis. | 2.30e-04 | 11 | 72 | 2 | 28694332 | |
| Pubmed | 2.30e-04 | 11 | 72 | 2 | 19902474 | ||
| Pubmed | Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. | 2.30e-04 | 11 | 72 | 2 | 23034650 | |
| Pubmed | 2.30e-04 | 11 | 72 | 2 | 20878950 | ||
| Pubmed | 2.30e-04 | 11 | 72 | 2 | 11944989 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | EHBP1 TLK1 TUT4 PTPRJ ZNF544 NECTIN2 RBM5 SRGAP2 JMJD1C GOLGA4 LRCH3 | 2.34e-04 | 1489 | 72 | 11 | 28611215 |
| Pubmed | 2.75e-04 | 12 | 72 | 2 | 29500366 | ||
| Pubmed | Susceptibility loci associated with prostate cancer progression and mortality. | 2.75e-04 | 12 | 72 | 2 | 20460480 | |
| Pubmed | 2.79e-04 | 151 | 72 | 4 | 17043677 | ||
| Pubmed | ABCF1 SACS TNPO2 SYNE1 GNPTAB APC YY1AP1 SRGAP2 EDIL3 DNAJA1 | 3.06e-04 | 1285 | 72 | 10 | 35914814 | |
| Interaction | KCNA3 interactions | EHBP1 CCDC73 SND1 EXPH5 NECTIN2 XRN1 APC DNAJA1 DNAH5 DHX29 JMJD1C GOLGA4 TFRC | 9.54e-06 | 871 | 71 | 13 | int:KCNA3 |
| Interaction | PHLPP1 interactions | 2.20e-05 | 333 | 71 | 8 | int:PHLPP1 | |
| Interaction | COPS5 interactions | BLM EHBP1 TUT4 ABCF1 COPZ1 TNPO2 MYLK4 MRPS11 APC RBM5 DNAJA1 DHX29 CRBN TFRC | 2.54e-05 | 1102 | 71 | 14 | int:COPS5 |
| Interaction | ATG16L1 interactions | POLR1F SND1 ADRM1 N4BP2 TNPO2 RBM10 NECTIN2 RBM26 APC LMTK2 SRGAP2 DNAJA1 LRCH3 TFRC | 4.50e-05 | 1161 | 71 | 14 | int:ATG16L1 |
| Interaction | NUP43 interactions | 6.43e-05 | 625 | 71 | 10 | int:NUP43 | |
| Interaction | SIRT6 interactions | 6.70e-05 | 628 | 71 | 10 | int:SIRT6 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.72e-05 | 23 | 40 | 3 | 1288 | |
| GeneFamily | RNA binding motif containing | 1.02e-04 | 213 | 40 | 5 | 725 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.70e-04 | 181 | 40 | 4 | 694 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 9.76e-04 | 21 | 40 | 2 | 89 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 1.07e-03 | 22 | 40 | 2 | 579 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 5.26e-03 | 49 | 40 | 2 | 584 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.09e-02 | 394 | 40 | 4 | 471 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.05e-05 | 656 | 71 | 10 | M18979 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | 2.37e-05 | 721 | 71 | 10 | M10237 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.67e-06 | 339 | 70 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | BLM POLR1F RIF1 TUT4 ABCF1 ADRM1 GNPTAB RBM26 APC DNA2 DNAJA1 IL18R1 RBM34 LRCH3 | 4.47e-05 | 1241 | 70 | 14 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | 5.83e-05 | 801 | 70 | 11 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.21e-04 | 146 | 70 | 5 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | BLM POLR1F RIF1 TAF3 TUT4 GNPTAB MYLK4 RBM26 APC DNA2 DNAJA1 IL18R1 LRCH3 | 2.00e-04 | 1252 | 70 | 13 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_500 | 2.37e-04 | 376 | 70 | 7 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_500 | 2.61e-04 | 382 | 70 | 7 | gudmap_developingGonad_e14.5_ ovary_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | BLM POLR1F RIF1 TUT4 ABCF1 ADRM1 GNPTAB RBM26 APC DNA2 DNAJA1 IL18R1 RBM34 LRCH3 | 2.65e-04 | 1468 | 70 | 14 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_500 | 2.78e-04 | 386 | 70 | 7 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 2.83e-04 | 387 | 70 | 7 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500 | 2.83e-04 | 387 | 70 | 7 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | 3.77e-04 | 406 | 70 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#1_top-relative-expression-ranked_500 | 4.03e-04 | 105 | 70 | 4 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k1_500 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.96e-06 | 153 | 72 | 5 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.96e-06 | 153 | 72 | 5 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 180 | 72 | 5 | d685fa2b013bc085dbef7c40956ed3043f83e483 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 183 | 72 | 5 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 184 | 72 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.42e-05 | 190 | 72 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 1.45e-05 | 191 | 72 | 5 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 1.49e-05 | 192 | 72 | 5 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 1.53e-05 | 193 | 72 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | Control-Myeloid-ncMonocyte|Control / Disease state, Lineage and Cell class | 1.61e-05 | 195 | 72 | 5 | fcb05948e7480dc53f06f3fc9b9c3fc129874edd | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.73e-05 | 198 | 72 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 1.81e-05 | 200 | 72 | 5 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.19e-04 | 156 | 72 | 4 | 6c8f442ed94ae31e6832b68137e98ae78091ac6c | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 158 | 72 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 158 | 72 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 1.66e-04 | 170 | 72 | 4 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.69e-04 | 171 | 72 | 4 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.73e-04 | 172 | 72 | 4 | 68fd03f2c8ee01fe46194400f74ede3830e00f34 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-04 | 172 | 72 | 4 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.85e-04 | 175 | 72 | 4 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 177 | 72 | 4 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-04 | 178 | 72 | 4 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-04 | 179 | 72 | 4 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 181 | 72 | 4 | 5a4574f1bfd0b4ca78da7effda43420857e17296 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-F_(Ciliated)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.11e-04 | 181 | 72 | 4 | a4e891603645f694687e68e585744ddc1a3c8697 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 181 | 72 | 4 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 2.11e-04 | 181 | 72 | 4 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.11e-04 | 181 | 72 | 4 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 181 | 72 | 4 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.20e-04 | 183 | 72 | 4 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 183 | 72 | 4 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 183 | 72 | 4 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 183 | 72 | 4 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 183 | 72 | 4 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 183 | 72 | 4 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 184 | 72 | 4 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 185 | 72 | 4 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 185 | 72 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 185 | 72 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-04 | 187 | 72 | 4 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-04 | 188 | 72 | 4 | 047c4e0b03fc8334e38c48977e41d26dbe229d47 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 2.53e-04 | 190 | 72 | 4 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | Control-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 2.58e-04 | 191 | 72 | 4 | 11dfd8f38beb294f42710cfbd355cb089e1023c0 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 2.58e-04 | 191 | 72 | 4 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.58e-04 | 191 | 72 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 2.58e-04 | 191 | 72 | 4 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-04 | 191 | 72 | 4 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.64e-04 | 192 | 72 | 4 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 2.64e-04 | 192 | 72 | 4 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 2.64e-04 | 192 | 72 | 4 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.69e-04 | 193 | 72 | 4 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.69e-04 | 193 | 72 | 4 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-04 | 193 | 72 | 4 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 2.69e-04 | 193 | 72 | 4 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 2.69e-04 | 193 | 72 | 4 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.74e-04 | 194 | 72 | 4 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | COPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class | 2.74e-04 | 194 | 72 | 4 | 7d682408e9a6239a4e47befc9376e760cc3d133a | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 2.74e-04 | 194 | 72 | 4 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.80e-04 | 195 | 72 | 4 | c9469e2d31beb30ebb64b3f0a5239e23119fbaa5 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Ciliated|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.80e-04 | 195 | 72 | 4 | cfcf554b436083179dea1d6fd6e3a800ea2430fe | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 195 | 72 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.80e-04 | 195 | 72 | 4 | 2f2e29089a8cb748d2c1329c5c8465165b25bc8b | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.80e-04 | 195 | 72 | 4 | f289a44010788853d7726d4b5aa75f3c62186c08 | |
| ToppCell | PSB-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.91e-04 | 197 | 72 | 4 | 6865f4831eb23794fb88a8649d48d497bbae3f44 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.91e-04 | 197 | 72 | 4 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 2.96e-04 | 198 | 72 | 4 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.96e-04 | 198 | 72 | 4 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.96e-04 | 198 | 72 | 4 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.02e-04 | 199 | 72 | 4 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | COVID-mono1|COVID / Condition, Cell_class and T cell subcluster | 3.08e-04 | 200 | 72 | 4 | bd002c54305c746c07b7418a2084195e9c852ec5 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.08e-04 | 200 | 72 | 4 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | COVID-mono1-|COVID / Condition, Cell_class and T cell subcluster | 3.08e-04 | 200 | 72 | 4 | 445a1aab962673dcc926c33ce9bed5ede9c41c57 | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.08e-04 | 200 | 72 | 4 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| Disease | Bloom syndrome (implicated_via_orthology) | 1.48e-05 | 3 | 66 | 2 | DOID:2717 (implicated_via_orthology) | |
| Disease | Werner syndrome (implicated_via_orthology) | 4.91e-05 | 5 | 66 | 2 | DOID:5688 (implicated_via_orthology) | |
| Disease | immature platelet count | 9.55e-05 | 106 | 66 | 4 | EFO_0803544 | |
| Disease | coffee consumption measurement, tea consumption measurement | 1.33e-04 | 44 | 66 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | free cholesterol in large LDL measurement | 2.06e-04 | 51 | 66 | 3 | EFO_0022176 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 2.06e-04 | 51 | 66 | 3 | EFO_0022242 | |
| Disease | susceptibility to bacterial meningitis measurement | 2.18e-04 | 52 | 66 | 3 | EFO_0008411 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.31e-04 | 53 | 66 | 3 | EFO_0022340 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.87e-04 | 57 | 66 | 3 | EFO_0022284 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 3.02e-04 | 58 | 66 | 3 | EFO_0022338 | |
| Disease | cholesterol in IDL measurement | 3.02e-04 | 58 | 66 | 3 | EFO_0021899 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 3.18e-04 | 59 | 66 | 3 | EFO_0022289 | |
| Disease | C-C motif chemokine 28 measurement | 3.21e-04 | 12 | 66 | 2 | EFO_0020199 | |
| Disease | total lipids in IDL | 3.34e-04 | 60 | 66 | 3 | EFO_0022161 | |
| Disease | free cholesterol in IDL measurement | 3.51e-04 | 61 | 66 | 3 | EFO_0022181 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 3.86e-04 | 63 | 66 | 3 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 3.86e-04 | 63 | 66 | 3 | EFO_0022239 | |
| Disease | interleukin 18 receptor 1 measurement | 5.08e-04 | 15 | 66 | 2 | EFO_0008178 | |
| Disease | shigellosis | 5.79e-04 | 16 | 66 | 2 | EFO_0005585 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 6.43e-04 | 75 | 66 | 3 | EFO_0022287 | |
| Disease | chronic obstructive pulmonary disease | 8.59e-04 | 688 | 66 | 7 | EFO_0000341 | |
| Disease | ulcerative colitis, Crohn's disease | 9.12e-04 | 20 | 66 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | trans fatty acid measurement, trans/trans-18:2 fatty acid measurement | 1.32e-03 | 24 | 66 | 2 | EFO_0006821, EFO_0006826 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.55e-03 | 26 | 66 | 2 | C0009405 | |
| Disease | Colorectal cancer | 1.67e-03 | 27 | 66 | 2 | cv:C0346629 | |
| Disease | COLORECTAL CANCER | 1.67e-03 | 27 | 66 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 1.67e-03 | 27 | 66 | 2 | cv:C0009404 | |
| Disease | hypertension, COVID-19 | 1.67e-03 | 27 | 66 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | remnant cholesterol measurement | 1.85e-03 | 108 | 66 | 3 | EFO_0010815 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 1.92e-03 | 29 | 66 | 2 | C1333990 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKFKNPNNVLIEQAE | 121 | Q86X53 | |
| KKALADQQKAQQPAV | 2526 | Q96L91 | |
| VADFNPETRQQKKKA | 51 | P0DKL9 | |
| KAKPQNKFAALDNEE | 186 | Q8NE71 | |
| KSPQMNDFNIKENKS | 141 | Q5JVX7 | |
| QDSKEAKKPNIINFD | 36 | Q96SW2 | |
| EQAATFKLEKNKQGQ | 276 | Q7Z478 | |
| DKNPNEGEKFKQISQ | 36 | P31689 | |
| FNKQDSKADVPQKAD | 191 | Q96LY2 | |
| ALKQTPKNNFAERQK | 351 | Q96LY2 | |
| SLNKQKENFKNSFQP | 661 | P98175 | |
| FQKKVQFGNENTKLE | 521 | Q5T8P6 | |
| RSVNKEKFKQQNSNP | 361 | P42696 | |
| EKFKQQNSNPRLKNV | 366 | P42696 | |
| AEPQNSFKELNNENK | 361 | H3BPF8 | |
| NPNQKDQKQKSALDE | 1246 | Q8N7Z5 | |
| KPKKDRQNVQQNEDA | 56 | P0C881 | |
| KPKKDRQNVQQNEDA | 56 | B2RC85 | |
| KDAKNNEVSFSQIKP | 1001 | Q12913 | |
| NKNPTIKKNAEFEDQ | 166 | Q13478 | |
| LDFVKQKASQSPQKQ | 506 | Q96II8 | |
| KKANQQLNFTEAKEA | 46 | Q9Y5Y7 | |
| LNNPKDFQELNKQTK | 271 | Q3T906 | |
| KKYQQKLEQEENPGN | 2086 | Q13439 | |
| NSSEQKPENELKNKN | 391 | Q15652 | |
| NDNAPKFQAENLDVK | 131 | Q9Y5H3 | |
| PSVKEQKAFEKNIFN | 36 | P61923 | |
| NAQKKKNRGSDAQDF | 371 | Q86YV6 | |
| REEKDNAGKNQKNQF | 921 | Q8NEV8 | |
| KASANPKEQDTFLKN | 171 | Q8IWU2 | |
| KANSNPFEVKVNRQK | 26 | P78316 | |
| LNKQKENFKNSFQPV | 551 | P52756 | |
| NKAQASPSEENKANK | 321 | Q5T2D3 | |
| SPSEENKANKNQLAK | 326 | Q5T2D3 | |
| QASPVAFKKINNNDD | 366 | P25929 | |
| KEQPFNHDINNELKK | 281 | O75344 | |
| KQRKDKVFQGNFDND | 426 | O43854 | |
| SFFKQNEKEKPQANV | 191 | Q9UEE9 | |
| TNQQRVKDFFKNAPA | 81 | P54132 | |
| ENKEKNPIKENFPFN | 441 | Q86Z20 | |
| DKKFQNVPEVNNENS | 391 | Q6ZRK6 | |
| KNKVKNQIYPEADFA | 581 | Q3MJ40 | |
| NPQDIKENNKKAYDG | 496 | Q8NDI1 | |
| FNQNKTTDPKEEIKQ | 311 | Q8IYD9 | |
| DQQKAPQTKNKADLQ | 126 | A0A1B0GTZ2 | |
| QKAKNPQEQKSFFAK | 211 | Q5UCC4 | |
| FQKAINNSFAPEKLQ | 166 | P51530 | |
| KFNGAQVNPKFKQCD | 3681 | Q9NZJ4 | |
| KKNNKPEVNQIANSD | 786 | Q01668 | |
| QKLKQNPNAKQFDFS | 451 | Q8TE73 | |
| ANQAKNQSAEAKEAK | 196 | Q96DX8 | |
| LNSENQPKKAVVADK | 371 | Q5VWG9 | |
| KAKQIAQKDVAFAPE | 2041 | Q8NF91 | |
| NAETEQNKKKADPEN | 1496 | Q5UIP0 | |
| APTANLDQKDKQFVA | 331 | Q7KZF4 | |
| TKDQQFKKDQNVLSP | 81 | P0DJJ0 | |
| TKDQQFKKDQNVLSP | 81 | P0DMP2 | |
| DKKNNRFNDGKVDPA | 96 | Q15493 | |
| ENADNNTKANVTKPK | 46 | P02786 | |
| EEKAKPFQNAAKQQA | 831 | O15047 | |
| PFQNAAKQQAKEEDK | 836 | O15047 | |
| AFAKAMQNNAKPEQK | 376 | Q16186 | |
| LKNNSKVFNDKLPNN | 1816 | P25054 | |
| NPNIKDSKDNQAKQN | 2691 | P25054 | |
| PKQRKNKAVNGAEND | 366 | Q9UKI8 | |
| QDAAAKQKVEQNAAP | 41 | P82912 | |
| PKDAAQQDAKAEENK | 166 | O14562 | |
| AAVAFKNAKQFEQAK | 41 | Q99747 | |
| DAQFNFNKKKNIAAE | 181 | Q8NDV3 | |
| VQDKLKQLNQFPDFN | 31 | O14787 | |
| TKDQQFKKDQNVLSP | 81 | O75044 | |
| RVANKKNFENKEAQS | 1611 | Q8IZH2 | |
| KKKHQEVQDQDPVFQ | 281 | Q3B726 | |
| SKPEDKQKAAAAFAQ | 791 | Q8IUG5 | |
| NPQDKILFTKAEDNK | 296 | Q9H869 | |
| KPNSQVKELKQNSAF | 186 | Q6NX49 | |
| NSIAEENKAKADQPK | 581 | Q5TAX3 | |
| QKVSPQQEKHKQNFA | 96 | Q8TCI5 | |
| NQNRAKEAFEKKISP | 496 | Q86UW6 | |
| KPKNQAEAQKVTFSQ | 161 | Q92692 |